PL3620452T3 - Sposób wytwarzania lenwatynibu - Google Patents
Sposób wytwarzania lenwatynibuInfo
- Publication number
- PL3620452T3 PL3620452T3 PL18193196T PL18193196T PL3620452T3 PL 3620452 T3 PL3620452 T3 PL 3620452T3 PL 18193196 T PL18193196 T PL 18193196T PL 18193196 T PL18193196 T PL 18193196T PL 3620452 T3 PL3620452 T3 PL 3620452T3
- Authority
- PL
- Poland
- Prior art keywords
- lenvatinib
- preparation
- Prior art date
Links
- WOSKHXYHFSIKNG-UHFFFAOYSA-N lenvatinib Chemical compound C=12C=C(C(N)=O)C(OC)=CC2=NC=CC=1OC(C=C1Cl)=CC=C1NC(=O)NC1CC1 WOSKHXYHFSIKNG-UHFFFAOYSA-N 0.000 title 1
- 229960003784 lenvatinib Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18193196.5A EP3620452B1 (en) | 2018-09-07 | 2018-09-07 | Process for the preparation of lenvatinib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3620452T3 true PL3620452T3 (pl) | 2021-10-25 |
Family
ID=63528608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18193196T PL3620452T3 (pl) | 2018-09-07 | 2018-09-07 | Sposób wytwarzania lenwatynibu |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11214543B2 (pl) |
| EP (1) | EP3620452B1 (pl) |
| JP (1) | JP7379470B2 (pl) |
| KR (1) | KR20210056390A (pl) |
| CN (1) | CN112654603B (pl) |
| CA (1) | CA3111875A1 (pl) |
| DK (1) | DK3620452T3 (pl) |
| ES (1) | ES2878275T3 (pl) |
| HU (1) | HUE055374T2 (pl) |
| IL (1) | IL281254B2 (pl) |
| PL (1) | PL3620452T3 (pl) |
| PT (1) | PT3620452T (pl) |
| SI (1) | SI3620452T1 (pl) |
| WO (1) | WO2020048963A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021217537A1 (zh) * | 2020-04-30 | 2021-11-04 | 天津睿创康泰生物技术有限公司 | 一种乐伐替尼游离碱晶型及其制备方法 |
| CN113045492A (zh) * | 2021-03-26 | 2021-06-29 | 成都倍特药业股份有限公司 | 一种甲磺酸仑伐替尼杂质、其制备方法和检测方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1415987B1 (en) | 2000-10-20 | 2007-02-28 | Eisai R&D Management Co., Ltd. | Nitrogenous aromatic ring compounds as anti cancer agents |
| CN101337930B (zh) * | 2003-11-11 | 2010-09-08 | 卫材R&D管理有限公司 | 脲衍生物的制备方法 |
| EP1894918A4 (en) * | 2005-06-23 | 2011-06-22 | Eisai R&D Man Co Ltd | AMORPHIC SALT OF 4- (3-CHLORO-4- (CYCLOPROPYLAMINOCARBONYL) AMINOPHENOXY) -7-METHOXY-6-CHINOLINE CARBOXAMIDE AND METHOD OF PREPARATION THEREOF |
| CN104876864B (zh) * | 2015-06-05 | 2017-03-08 | 北京康立生医药技术开发有限公司 | 一种乐伐替尼的制备方法 |
| CN107266363A (zh) | 2016-04-06 | 2017-10-20 | 杭州华东医药集团新药研究院有限公司 | 甲磺酸乐伐替尼药物杂质的制备方法 |
| CN106632033A (zh) * | 2016-10-28 | 2017-05-10 | 北京万全德众医药生物技术有限公司 | 乐伐替尼的一种制备方法 |
| CN108299294A (zh) * | 2017-01-11 | 2018-07-20 | 江苏恒瑞医药股份有限公司 | 一种乐伐替尼杂质的制备方法 |
| WO2019016664A1 (en) * | 2017-07-20 | 2019-01-24 | Bdr Lifesciences Private Limited | IMPROVED PROCESS FOR THE PREPARATION OF LENVATINIB |
| CN107739335A (zh) * | 2017-12-01 | 2018-02-27 | 南京奇可药业有限公司 | 一种乐伐替尼的合成方法 |
| CN108997214A (zh) * | 2018-06-13 | 2018-12-14 | 成都地奥制药集团有限公司 | 乐伐替尼中间体及其制备和乐伐替尼的制备 |
| CN110818634B (zh) * | 2018-08-13 | 2021-11-30 | 上海新礼泰药业有限公司 | 甲磺酸乐伐替尼的精制方法 |
| CN109734661B (zh) * | 2018-09-10 | 2021-12-21 | 江苏工程职业技术学院 | 一种乐伐替尼的合成方法 |
| CN109456267A (zh) * | 2018-12-28 | 2019-03-12 | 南京天越星生物技术有限公司 | 一种合成乐伐替尼的方法 |
| CN110981800A (zh) * | 2019-12-31 | 2020-04-10 | 安徽省诚联医药科技有限公司 | 一种乐伐替尼的制备方法 |
| CN113307767A (zh) * | 2021-06-18 | 2021-08-27 | 山东汇海医药化工有限公司 | 一种乐伐替尼的合成方法 |
-
2018
- 2018-09-07 SI SI201830300T patent/SI3620452T1/sl unknown
- 2018-09-07 DK DK18193196.5T patent/DK3620452T3/da active
- 2018-09-07 ES ES18193196T patent/ES2878275T3/es active Active
- 2018-09-07 HU HUE18193196A patent/HUE055374T2/hu unknown
- 2018-09-07 PL PL18193196T patent/PL3620452T3/pl unknown
- 2018-09-07 EP EP18193196.5A patent/EP3620452B1/en active Active
- 2018-09-07 PT PT181931965T patent/PT3620452T/pt unknown
-
2019
- 2019-09-03 JP JP2021512797A patent/JP7379470B2/ja active Active
- 2019-09-03 IL IL281254A patent/IL281254B2/en unknown
- 2019-09-03 US US17/273,740 patent/US11214543B2/en active Active
- 2019-09-03 WO PCT/EP2019/073442 patent/WO2020048963A1/en active Application Filing
- 2019-09-03 KR KR1020217010238A patent/KR20210056390A/ko active Search and Examination
- 2019-09-03 CA CA3111875A patent/CA3111875A1/en active Pending
- 2019-09-03 CN CN201980058309.7A patent/CN112654603B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT3620452T (pt) | 2021-07-06 |
| DK3620452T3 (da) | 2021-06-14 |
| CA3111875A1 (en) | 2020-03-12 |
| JP2021536481A (ja) | 2021-12-27 |
| KR20210056390A (ko) | 2021-05-18 |
| US11214543B2 (en) | 2022-01-04 |
| ES2878275T3 (es) | 2021-11-18 |
| IL281254B2 (en) | 2024-02-01 |
| CN112654603B (zh) | 2024-05-03 |
| JP7379470B2 (ja) | 2023-11-14 |
| EP3620452B1 (en) | 2021-05-19 |
| IL281254B1 (en) | 2023-10-01 |
| SI3620452T1 (sl) | 2021-08-31 |
| US20210246107A1 (en) | 2021-08-12 |
| HUE055374T2 (hu) | 2021-11-29 |
| CN112654603A (zh) | 2021-04-13 |
| WO2020048963A1 (en) | 2020-03-12 |
| EP3620452A1 (en) | 2020-03-11 |
| IL281254A (en) | 2021-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276917A (en) | A process for the preparation of alubixivet | |
| SI3433285T1 (sl) | Izboljšan postopek za pripravo sugamadeksa | |
| GB2593352B (en) | Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (brexanolone) | |
| SG11202005382YA (en) | Process for the preparation of microcapsules | |
| EP3694499A4 (en) | NEW LIFITEGRAST PREPARATION PROCESS | |
| PL3765440T3 (pl) | Sposób wytwarzania n-alkilonitratoetylonitroamin | |
| IL281254A (en) | A process for the preparation of lanbatinib | |
| HUE059152T2 (hu) | Eljárás metil-merkaptán elõállítására | |
| IL275480A (en) | A process for the preparation of pyrimidinyl-4-aminopyrazole compounds | |
| IL268835B (en) | A process for the preparation of 2-cyanoimidazole compounds | |
| IL289904A (en) | A process for preparing biphenylamines | |
| EP3877361C0 (en) | PROCESS FOR PREPARING ARYLSULFONYLPROPENENITRILE | |
| IL279410A (en) | Process for preparing Quinmark | |
| IL277956B1 (en) | Process for preparing Ilufrost | |
| PL3599256T3 (pl) | Sposób wytwarzania poliorganosiloksanów | |
| ZA202002116B (en) | Process for the preparation of piperine | |
| IL275381A (en) | A process for the preparation of Crisborole | |
| GB2572385B (en) | Process for the preparation of glycidol | |
| HUP1800278A2 (en) | Process for the preparation of boc-linagliptin | |
| IL276557A (en) | A process for making metformin | |
| HUE058725T2 (hu) | Eljárás aminok elõállítására | |
| GB2573115B (en) | Process for the preparation of oxamyl | |
| IL274560A (en) | A process for the preparation of raltagravir | |
| IL274487A (en) | A process for the preparation of fluoficolide | |
| PT3604272T (pt) | Processo para a preparação de gabapentina |